Evidence map›Paper›PMID 21683169›Full record

ReviewBiochimica et biophysica acta2012

Proteases as regulators of pathogenesis: examples from the Apicomplexa.

Hao Li, Matthew A Child, Matthew Bogyo

Abstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Cells · 2025
    Article
  4. Article
  5. Article
  6. Analysis of Volatile Secondary Metabolites inPlants (Basel, Switzerland) · 2022
    Article
  7. Targeting theHeliyon · 2022
    Review
  8. Article
  9. Eimeria proteins: order amidst disorder.Parasites & vectors · 2022
    Review
  10. Comparison of high throughput RNA sequences betweenFrontiers in cellular and infection microbiology · 2022
    Article
  11. In Silico Survey and Characterization ofPathogens (Basel, Switzerland) · 2021
    Article
  12. Article
  13. Bio-Insecticide ofInsects · 2021
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Hao LiDepartments of Pathology and Microbiology and Immunology, Stanford University, Standford, CA 94305, USA.
Matthew A Child
Matthew Bogyo
Stanford University · US

Funding

Small Molecule Imaging of Protease ActivityR01EB005011 · NIBIB · STANFORD UNIVERSITY · PI BOGYO, MATTHEW · 2005 to 2013
$3.0M
Chemically Mapping Malarial Rupture ProteasesR01AI078947 · NIAID · STANFORD UNIVERSITY · PI BOGYO, MATTHEW · 2009 to 2013
$2.0M
Chemical characterization of SUMO specific proteases in Plasmodium falciparumR21AI088541 · NIAID · STANFORD UNIVERSITY · PI BOGYO, MATTHEW · 2010 to 2011
$438k
NIAID NIH HHS R01 AI078947NIAID NIH HHS R21 AI088541NIBIB NIH HHS R01 EB005011
6 · The paper itself

Abstract

The diverse functional roles that proteases play in basic biological processes make them essential for virtually all organisms. Not surprisingly, proteolysis is also a critical process required for many aspects of pathogenesis. In particular, obligate intracellular parasites must precisely coordinate proteolytic events during their highly regulated life cycle inside multiple host cell environments. Advances in chemical, proteomic and genetic tools that can be applied to parasite biology have led to an increased understanding of the complex events centrally regulated by proteases. In this review, we outline recent advances in our knowledge of specific proteolytic enzymes in two medically relevant apicomplexan parasites: Plasmodium falciparum and Toxoplasma gondii. Efforts over the last decade have begun to provide a map of key proteotolyic events that are essential for both parasite survival and propagation inside host cells. These advances in our molecular understanding of proteolytic events involved in parasite pathogenesis provide a foundation for the validation of new networks and enzyme targets that could be exploited for therapeutic purposes. This article is part of a Special Issue entitled: Proteolysis 50 years after the discovery of lysosome.

Indexed as

Host-Parasite InteractionsAnimalsApicomplexaDiseaseDrug DesignHumansImmunityModels, BiologicalPeptide HydrolasesProtozoan InfectionsPeptide Hydrolases

Identifiers

PMID21683169
PMCPMC3232290
OpenAlexW2090160626

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.